AMCINONIDE

Post-LOE

amcinonide

Taro

ANDATOPICALOINTMENT

Approved

Mar 2003

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

3/8 — Basic

AMCINONIDE (amcinonide) by Taro is corticosteroid hormone receptor agonists [moa]. First approved in 2003.

Drug data last refreshed 2h ago

$0.0BPart D

Mechanism of Action

Corticosteroid Hormone Receptor Agonists

Pharmacologic Class:

Corticosteroid

Indications

Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.

Company

Taro

See all Taro products →

Worked on AMCINONIDE at Taro? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.